Should You Be Worried About AstraZeneca Stock?

Zhiyuan Sun, The Motley Fool
·4 min read
Should You Be Worried About AstraZeneca Stock?
Should You Be Worried About AstraZeneca Stock?

According to a recent poll by CNN, only one out of two Americans plan on getting a coronavirus vaccine once one is approved. Before the pandemic, the fastest vaccine ever developed was the mumps vaccine, and that took four years. Meanwhile, the fact that we are rushing vaccines to the market in less than 12 months has many Americans worried about their quality and long-term safety profile, which ongoing clinical studies cannot yet evaluate.